NTRA
NTRA
US6323071042
Natera, Inc.
Loading chart...

Company Profile

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company has a collaboration with Diakonos Oncology Corp. to assess molecular response in patients with refractory melanoma. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.

Latest News

Related stocks

IDXX
IDXX • United States
IDEXX Laboratories, Inc.
518 USD
40.86B USD 1Y -18.5%
ILMN
ILMN • United States
Illumina, Inc.
278.17 USD
42B USD 1Y +170.6%
A
A • United States
Agilent Technologies, Inc.
170.54 USD
48.08B USD 1Y +19.4%
IQV
IQV • United States
IQVIA Holdings, Inc.
259.88 USD
42.78B USD 1Y +29.1%
WAT
WAT • United States
Waters Corporation
433.77 USD
42.59B USD 1Y +31%
GH
GH • United States
Guardant Health, Inc.
167.47 USD
22.47B USD 1Y +153.5%
CRL
CRL • United States
Charles River Laboratories Inte
301.79 USD
14.41B USD 1Y +71.8%
MEDP
MEDP • United States
Medpace Holdings, Inc.
612.05 USD
17.08B USD 1Y +13.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
57.6% p.a.
Max Drawdown (5Y)
-76.4%
Sharpe Ratio (5Y)
0.44
Beta Factor
1.50
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (57.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -77.7% in the extended horizon.
ende